Mustang Bio MBIO
NASDAQ MBIO
$0.57 +0.01 (+1.22%)
As of: Aug 21, 2026 · 12:04 PM EDT

Mustang Bio (MBIO) Revenue (2018)

Mustang Bio (MBIO) posted quarterly Revenue of $50000.0 for Q1 2018.

Mustang Bio (MBIO) Revenue (2018) Analysis & Trends

Mustang Bio (MBIO) has reported Revenue for 1 consecutive years, with $50000.0 the latest figure, recorded in Q1 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 139.69 Bn 131.84 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 86.54 Bn 78.54 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 65.27 Bn 60.09 Bn 1.37 Bn 1.52 Bn
4 Moderna 59.41 Bn 54.27 Bn 52.00 Mn 145.00 Mn
5 BeOne Medicines 42.12 Bn 37.02 Bn 1.53 Bn 1.71 Bn
6 Alnylam Pharmaceuticals 31.80 Bn 28.49 Bn 992.69 Mn 1.29 Bn
7 BioNTech SE 28.07 Bn 9.68 Bn 668.28 Mn 1.06 Bn
8 Insmed 27.55 Bn 26.39 Bn 358.27 Mn 425.49 Mn
9 Royalty Pharma 27.28 Bn 26.44 Bn - 674.14 Mn
10 Mustang Bio 3.87 Mn 3.87 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2018 50,000.00